Linda and Kenneth Pollin Foundation, Inc. Report issue

Foundation

Organization Overview

First Clinical Trial
2005
NCT00272142
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (1)

zinc (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1